Clarius Group LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $387K | Sell |
|
|||||
|
2025
Q2 | $723K | Sell |
|
|||||
|
2025
Q1 | $881K | Buy |
|
|||||
|
2024
Q4 | $555K | Sell |
|
|||||
|
2024
Q3 | $700K | Sell |
|
|||||
|
2024
Q2 | $729K | Sell |
|
|||||
|
2024
Q1 | $690K | Sell |
|
|||||
|
2023
Q4 | $797K | Sell |
|
|||||
|
2023
Q3 | $725K | Sell |
|
|||||
|
2023
Q2 | $880K | Buy |
|
|||||
|
2023
Q1 | $773K | Sell |
|
|||||
|
2022
Q4 | $740K | Buy |
|
|||||
|
2022
Q3 | $724K | Buy |
|
|||||
|
2022
Q2 | $686K | Buy |
|
|||||
|
2022
Q1 | $466K | Hold |
|
|||||
|
2021
Q4 | $466K | Sell |
|
|||||
|
2021
Q3 | $398K | Buy |
|
|||||
|
2021
Q2 | $426K | Sell |
|
|||||
|
2021
Q1 | $459K | Buy |
|
|||||
|
2020
Q4 | $429K | Buy |
|
|||||
|
2020
Q3 | $458K | Sell |
|
|||||
|
2020
Q2 | $496K | Buy |
|
|||||
|
2020
Q1 | $370K | Buy |
|
|||||
|
2019
Q4 | $340K | Buy |
|
|||||
|
2019
Q3 | $239K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $212K | Buy |
|